Indicators

Markets:

News

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9

...

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

July 16, 2024

Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

July 11, 2024

Pfizer moves forward with once-daily version of weight loss pill after setbacks

July 11, 2024

Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'

July 10, 2024

Jim Cramer reviews 8 companies that could top $1 trillion in market cap

July 10, 2024

FTC to sue drug middlemen over prices of medications including insulin

July 10, 2024

Companies besides tech can reach megacap status, Jim Cramer says

July 08, 2024

This ETF is trying to satisfy appetites for weight loss stocks

July 06, 2024

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

July 03, 2024

CNBC Daily Open: Tesla soars, S&P closes above 5,500

July 03, 2024

CNBC Daily Open: Tesla soars, S&P closes above 5,500

July 02, 2024

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

July 02, 2024

Watch now: ETF Edge on reshoring trends, weight loss drugs and more

July 01, 2024

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

June 26, 2024

Jim Cramer's top picks for pet-centric stocks

June 25, 2024

Novo Nordisk's Wegovy weight loss drug approved in China

June 25, 2024

Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

June 24, 2024

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

June 21, 2024

Weight loss drug contender Zealand Pharma jumps 23% on trial results

June 21, 2024

Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

June 18, 2024

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

June 17, 2024

Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug

June 11, 2024

FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval

June 10, 2024

Jim Cramer's week ahead: Fed meeting and CPI report

June 07, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI

June 06, 2024

Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO

June 05, 2024

Why half of all workers may struggle to get weight-loss drug health insurance coverage

May 30, 2024

Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages

May 29, 2024

This new weight loss drug ETF bets big on two of the industry's leading players

May 27, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.